Search research articles
Contact Us
Filters
Showing results (11-20 of 15) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 15 results.
Organic Letters
|
February 29, 2020
Nine-Step Stereoselective Synthesis of Islatravir from Deoxyribose
Christopher C Nawrat, Aaron M Whittaker, Mark A Huffman, et al.
Organic Letters
|
June 10, 2020
Synthesis of Islatravir Enabled by a Catalytic, Enantioselective Alkynylation of a Ketone
Niki R Patel, Christopher C Nawrat, Mark McLaughlin, et al.
Organic Letters
|
January 13, 2026
Asymmetric Synthesis of KRAS G12C Inhibitor MK-1084 via a Crystallization-Induced Diastereomer Transformation (CIDT)
Hongming Li, Gao Shang, Zhiguo J Song, et al.
Science (New York, N.Y.)
|
December 7, 2019
Design of an in vitro biocatalytic cascade for the manufacture of islatravir
Mark A Huffman, Anna Fryszkowska, Oscar Alvizo, et al.
Journal of Medicinal Chemistry
|
February 16, 2024
Invention of MK-7845, a SARS-CoV-2 3CL Protease Inhibitor Employing a Novel Difluorinated Glutamine Mimic
Valerie W Shurtleff, Mark E Layton, Craig A Parish, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 15) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 15 results.
Organic Letters
|
February 29, 2020
Nine-Step Stereoselective Synthesis of Islatravir from Deoxyribose
Christopher C Nawrat, Aaron M Whittaker, Mark A Huffman, et al.
Organic Letters
|
June 10, 2020
Synthesis of Islatravir Enabled by a Catalytic, Enantioselective Alkynylation of a Ketone
Niki R Patel, Christopher C Nawrat, Mark McLaughlin, et al.
Organic Letters
|
January 13, 2026
Asymmetric Synthesis of KRAS G12C Inhibitor MK-1084 via a Crystallization-Induced Diastereomer Transformation (CIDT)
Hongming Li, Gao Shang, Zhiguo J Song, et al.
Science (New York, N.Y.)
|
December 7, 2019
Design of an in vitro biocatalytic cascade for the manufacture of islatravir
Mark A Huffman, Anna Fryszkowska, Oscar Alvizo, et al.
Journal of Medicinal Chemistry
|
February 16, 2024
Invention of MK-7845, a SARS-CoV-2 3CL Protease Inhibitor Employing a Novel Difluorinated Glutamine Mimic
Valerie W Shurtleff, Mark E Layton, Craig A Parish, et al.
Page
of 2